Meta-analysis of randomized controlled trials on the efficacy and safety of intracoronary administration of tirofiban for no-reflow phenomenon

BACKGROUND: Currently, there is still a lack of an optimal treatment for no-reflow phenomenon (NR). The aim of this simple meta-analysis was to evaluate the efficacy and safety of intracoronary (IC) administration of tirofiban compared with other conventional drugs during percutaneous coronary inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Tao, Xie, Lu, Chen, Meng-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847195/
https://www.ncbi.nlm.nih.gov/pubmed/24016038
http://dx.doi.org/10.1186/1471-2261-13-68

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847195/
https://www.ncbi.nlm.nih.gov/pubmed/24016038
http://dx.doi.org/10.1186/1471-2261-13-68

Ejemplares similares